Research graph
References from Interplay between biofilm microenvironment and pathogenicity of Pseudomonas aeruginosa in cystic fibrosis lung chronic infection. Local targets link to admitted publications; unresolved targets remain external evidence.
Interclonal gradient of virulence in the Pseudomonas aeruginosa pangenome from disease and environment
10.1111/1462-2920.12606 · 2015 · External reference
Epidemiology of cystic fibrosis
2007 · External reference
Pseudomonas aeruginosa aggregates in cystic fibrosis sputum produce exopolysaccharides that likely impede current therapies
10.1016/j.celrep.2021.108782 · 2021 · External reference
Recent advances in the treatment of Pseudomonas aeruginosa infections in cystic fibrosis
10.1186/1741-7015-9-32 · 2011 · External reference
Early adaptive developments of Pseudomonas aeruginosa after the transition from life in the environment to persistent colonization in the airways of human cystic fibrosis hosts
10.1111/j.1462-2920.2010.02211.x · 2010 · External reference
Adaptive resistance to tobramycin in Pseudomonas aeruginosa lung infection in cystic fibrosis
10.1093/jac/37.6.1155 · 1996 · External reference
Adaptive resistance to the “last hope” antibiotics polymyxin B and colistin in Pseudomonas aeruginosa is mediated by the novel two-component regulatory system ParR-ParS
10.1128/aac.00242-10 · 2010 · External reference
Aminoglycoside-resistance mechanisms for cystic fibrosis Pseudomonas aeruginosa isolates are unchanged by long-term, intermittent, inhaled tobramycin treatment
10.1086/315312 · 2000 · External reference
Alginate overproduction affects Pseudomonas aeruginosa biofilm structure and function
10.1128/jb.183.18.5395-5401.2001 · 2001 · External reference
New opportunities for managing acute and chronic lung infections
10.1038/nrmicro.2017.122 · 2018 · External reference
Emerging cystic fibrosis pathogens and the microbiome
2014 · External reference
Detection and accurate identification of new or emerging bacteria in cystic fibrosis patients
10.1111/j.1469-0691.2010.03236.x · 2010 · External reference
Regulation of biofilm exopolysaccharide biosynthesis and degradation in Pseudomonas aeruginosa
10.1146/annurev-micro-041320-111355 · 2022 · External reference
Pseudomonas aeruginosa biofilms in cystic fibrosis
10.2217/fmb.10.125 · 2010 · External reference
Incidence of mucoid Pseudomonas aeruginosa from clinical sources
10.1128/am.18.5.936-937.1969 · 1969 · External reference
A polysaccharide resembling alginic acid from a Pseudomonas micro-organism
10.1038/204187a0 · 1964 · External reference
Production and characterization of the slime polysaccharide of Pseudomonas aeruginosa
10.1128/jb.116.2.915-924.1973 · 1973 · External reference
Alginate synthesis by Pseudomonas aeruginosa: a key pathogenic factor in chronic pulmonary infections of cystic fibrosis patients
10.1128/cmr.4.2.191 · 1991 · External reference
Heterogeneity of biofilms formed by nonmucoid Pseudomonas aeruginosa isolates from patients with cystic fibrosis
10.1128/jcm.43.10.5247-5255.2005 · 2005 · External reference
Structures, properties and application of alginic acid: a review
10.1016/j.ijbiomac.2020.06.180 · 2020 · External reference
Extracellular pH and lung infections in cystic fibrosis
10.1016/j.ejcb.2018.06.001 · 2018 · External reference
Exhaled breath condensate pH and exhaled nitric oxide in allergic asthma and in cystic fibrosis
10.1136/thx.2003.017327 · 2005 · External reference
Conformational and configurational features of acidic polysaccharides and their interactions with calcium ions: a molecular modeling investigation
10.1016/s0008-6215(99)00062-2 · 1999 · External reference
Elevated metal concentrations in the CF airway correlate with cellular injury and disease severity
10.1016/j.jcf.2013.12.001 · 2014 · External reference
Production of mucoid microcolonies by Pseudomonas aeruginosa within infected lungs in cystic fibrosis
10.1128/iai.28.2.546-556.1980 · 1980 · External reference
Antibiotic interaction and diffusion through alginate and exopolysaccharide of cystic fibrosis-derived Pseudomonas aeruginosa
10.1093/jac/22.5.667 · 1988 · External reference
Inhibition of tobramycin diffusion by binding to alginate
10.1128/aac.32.4.518 · 1988 · External reference
Biodegradable intraoperative system for bone infection treatment. I. The drug/polymer interaction
10.1016/s0378-5173(96)04703-5 · 1996 · External reference
Interaction of gentamicin sulfate with alginate and consequences on the physico-chemical properties of alginate-containing biofilms
10.1016/j.ijbiomac.2018.10.025 · 2019 · External reference
Stiffness of cross-linked poly(dimethylsiloxane) affects bacterial adhesion and antibiotic susceptibility of attached cells
10.1021/la502029f · 2014 · External reference
Analysis of the alginate O-acetylation machinery in Pseudomonas aeruginosa
10.1007/s00253-019-10310-6 · 2020 · External reference
The role of intermolecular interactions: studies on model systems for bacterial biofilms
10.1016/s0141-8130(99)00057-4 · 1999 · External reference
Role of alginate O acetylation in resistance of mucoid Pseudomonas aeruginosa to opsonic phagocytosis
10.1128/iai.69.3.1895-1901.2001 · 2001 · External reference
Alginate-modifying enzymes: biological roles and biotechnological uses
2015 · External reference
Alginate lyase exhibits catalysis-independent biofilm dispersion and antibiotic synergy
10.1128/aac.01789-12 · 2013 · External reference
Effect of acetylation on some solution and gelling properties of alginates
10.1016/0008-6215(89)84028-5 · 1989 · External reference
Evidence for airway surface dehydration as the initiating event in CF airway disease
10.1111/j.1365-2796.2006.01744.x · 2007 · External reference
The sigma factor AlgU (AlgT) controls exopolysaccharide production and tolerance towards desiccation and osmotic stress in the biocontrol agent Pseudomonas fluorescens CHA0
10.1128/aem.67.12.5683-5693.2001 · 2001 · External reference
Pulmonary dehydration and infection in cystic fibrosis: evidence that ethanol activates alginate gene expression and induction of mucoidy in Pseudomonas aeruginosa
10.1111/j.1365-2958.1990.tb00644.x · 1990 · External reference
Low concentrations of ethanol stimulate biofilm and pellicle formation in Pseudomonas aeruginosa
10.1080/09168451.2014.877828 · 2014 · External reference
Mechanisms and regulation of extracellular DNA release and its biological roles in microbial communities
10.3389/fmicb.2017.01390 · 2017 · External reference
Studies on pulmonary secretions. 3. The nucleic acids in whole pulmonary secretions from patients with cystic fibrosis, bronchiectasis, and laryngectomy
1969 · External reference
In vivo effects of recombinant human DNase I on sputum in patients with cystic fibrosis
10.1136/thx.51.2.119 · 1996 · External reference
Pus, deoxyribonucleic acid, and sputum viscosity
10.1136/thx.33.2.235 · 1978 · External reference
Extracellular DNA chelates cations and induces antibiotic resistance in Pseudomonas aeruginosa biofilms
10.1371/journal.ppat.1000213 · 2008 · External reference
DNA-cation interactions: quo vadis?
10.1016/s1074-5521(02)00116-3 · 2002 · External reference
Submillimolar levels of calcium regulates DNA structure at the dinucleotide repeat (TG/AC)n
10.1073/pnas.95.11.5981 · 1998 · External reference
Targeted disruption of the extracellular polymeric network of Pseudomonas aeruginosa biofilms by alginate oligosaccharides
10.1038/s41522-018-0056-3 · 2018 · External reference
Explosive cell lysis as a mechanism for the biogenesis of bacterial membrane vesicles and biofilms
10.1038/ncomms11220 · 2016 · External reference
The origin of extracellular DNA in bacterial biofilm infections in vivo
10.1093/femspd/ftaa018 · 2020 · External reference
Extracellular DNA shields against aminoglycosides in Pseudomonas aeruginosa biofilms
10.1128/aac.00001-13 · 2013 · External reference
A characterization of DNA release in Pseudomonas aeruginosa cultures and biofilms
10.1111/j.1365-2958.2005.05008.x · 2006 · External reference
The origin of DNA associated with mucus glycoproteins in cystic fibrosis sputum
10.1183/09031936.93.03010019 · 1990 · External reference
Understanding the entanglement: neutrophil extracellular traps (NETs) in cystic fibrosis
10.3389/fcimb.2017.00104 · 2017 · External reference
Extracellular DNA required for bacterial biofilm formation
10.1126/science.295.5559.1487 · 2002 · External reference
The exopolysaccharide Psl-eDNA interaction enables the formation of a biofilm skeleton in Pseudomonas aeruginosa
10.1111/1758-2229.12252 · 2015 · External reference
The biofilm matrix scaffold of Pseudomonas aeruginosa contains G-quadruplex extracellular DNA structures
10.1038/s41522-021-00197-5 · 2021 · External reference
Extracellular DNA plays a key role in deep-sea ecosystem functioning
10.1126/science.1117475 · 2005 · External reference
Pseudomonas aeruginosa produces an extracellular deoxyribonuclease that is required for utilization of DNA as a nutrient source
10.1111/j.1462-2920.2010.02208.x · 2010 · External reference
Antibiotic stress induces genetic transformability in the human pathogen Streptococcus pneumoniae
10.1126/science.1127912 · 2006 · External reference
Extracellular DNA release acts as an antifungal resistance mechanism in mature Aspergillus fumigatus biofilms
10.1128/ec.00287-12 · 2013 · External reference
The Pseudomonas aeruginosa pan-genome provides new insights on its population structure, horizontal gene transfer, and pathogenicity
10.1093/gbe/evy259 · 2018 · External reference
Role of horizontal gene transfer in the evolution of Pseudomonas aeruginosa virulence
10.1159/000235767 · 2009 · External reference
Extracellular DNA acidifies biofilms and induces aminoglycoside resistance in Pseudomonas aeruginosa
10.1128/aac.01650-15 · 2016 · External reference
Genes involved in matrix formation in Pseudomonas aeruginosa PA14 biofilms
10.1046/j.1365-2958.2003.03877.x · 2004 · External reference
Pel is a cationic exopolysaccharide that cross-links extracellular DNA in the Pseudomonas aeruginosa biofilm matrix
10.1073/pnas.1503058112 · 2015 · External reference
New perspectives at the heart of surface-associated microbial communities
10.1128/jb.00332-10 · 2009 · External reference
The pel polysaccharide can serve a structural and protective role in the biofilm matrix of Pseudomonas aeruginosa
10.1371/journal.ppat.1001264 · 2011 · External reference
Facultative control of matrix production optimizes competitive fitness in Pseudomonas aeruginosa PA14 biofilm models
10.1128/aem.02628-15 · 2015 · External reference
Pseudomonas aeruginosa anaerobic respiration in biofilms: relationships to cystic fibrosis pathogenesis
10.1016/s1534-5807(02)00295-2 · 2002 · External reference
Hypoxia and sterile inflammation in cystic fibrosis airways: mechanisms and potential therapies
10.1183/13993003.00903-2016 · 2017 · External reference
Oxygen limitation contributes to antibiotic tolerance of Pseudomonas aeruginosa in biofilms
10.1128/aac.48.7.2659-2664.2004 · 2004 · External reference
Aminoglycoside resistance of Pseudomonas aeruginosa biofilms modulated by extracellular polysaccharide
2010 · External reference
Two genetic loci produce distinct carbohydrate-rich structural components of the Pseudomonas aeruginosa biofilm matrix
10.1128/jb.186.14.4457-4465.2004 · 2004 · External reference
Pseudomonas aeruginosa Psl is a galactose- and mannose-rich exopolysaccharide
10.1128/jb.00620-07 · 2007 · External reference
Genetic and biochemical analyses of the Pseudomonas aeruginosa Psl exopolysaccharide reveal overlapping roles for polysaccharide synthesis enzymes in Psl and LPS production
10.1111/j.1365-2958.2009.06795.x · 2009 · External reference
Synthesis of multiple Pseudomonas aeruginosa biofilm matrix exopolysaccharides is post-transcriptionally regulated
10.1111/j.1462-2920.2012.02753.x · 2012 · External reference
The Pel and Psl polysaccharides provide Pseudomonas aeruginosa structural redundancy within the biofilm matrix
10.1111/j.1462-2920.2011.02657.x · 2012 · External reference
Evolutionary adaptations of biofilms infecting cystic fibrosis lungs promote mechanical toughness by adjusting polysaccharide production
10.1038/s41522-016-0007-9 · 2017 · External reference
Assembly and development of the Pseudomonas aeruginosa biofilm matrix
10.1371/journal.ppat.1000354 · 2009 · External reference
Pseudomonas aeruginosa Psl polysaccharide reduces neutrophil phagocytosis and the oxidative response by limiting complement-mediated opsonization
10.1111/j.1462-5822.2011.01704.x · 2012 · External reference
Psl produced by mucoid Pseudomonas aeruginosa contributes to the establishment of biofilms and immune evasion
10.1128/mbio.00864-17 · 2017 · External reference
Pseudomonas aeruginosa uses a cyclic-di-GMP-regulated adhesin to reinforce the biofilm extracellular matrix
10.1111/j.1365-2958.2009.06991.x · 2010 · External reference
CdrA interactions within the Pseudomonas aeruginosa biofilm matrix safeguard it from proteolysis and promote cellular packing
10.1128/mbio.01376-18 · 2018 · External reference
The Pseudomonas aeruginosa lectin LecB binds to the exopolysaccharide Psl and stabilizes the biofilm matrix
10.1038/s41467-019-10201-4 · 2019 · External reference
Tasked with a challenging objective: why do neutrophils fail to battle Pseudomonas aeruginosa biofilms
10.3390/pathogens8040283 · 2019 · External reference
Microbial pathogenesis in cystic fibrosis: mucoid Pseudomonas aeruginosa and Burkholderia cepacia
10.1128/mr.60.3.539-574.1996 · 1996 · External reference
The extracellular matrix component psl provides fast-acting antibiotic defense in Pseudomonas aeruginosa biofilms
10.1371/journal.ppat.1003526 · 2013 · External reference
Mucus and mucins in diseases of the intestinal and respiratory tracts
10.1111/joim.12910 · 2019 · External reference
Aggregation phenomena in aqueous solutions of hydrophobically modified polyelectrolytes
10.1021/ma981946k · 1999 · External reference
Concentrated solutions of salivary MUC5B mucin do not replicate the gel-forming properties of saliva
10.1042/bj3620289 · 2002 · External reference
Saliva as research material: biochemical, physicochemical and practical aspects
10.1016/j.archoralbio.2007.06.009 · 2007 · External reference
Mucins as multifunctional building blocks of biomaterials
10.1039/c8bm00471d · 2018 · External reference
Novel anti-inflammatory approaches for cystic fibrosis lung disease: identification of molecular targets and design of innovative therapies
10.3389/fphar.2020.01096 · 2020 · External reference
Interleukin-1β and tumor necrosis factor-α induce MUC5AC overexpression through a mechanism involving ERK/p38 mitogen-activated protein kinases-MSK1-CREB activation in human airway epithelial cells
10.1074/jbc.m300096200 · 2003 · External reference
Mucin promotes rapid surface motility in Pseudomonas aeruginosa
10.1128/mbio.00073-12 · 2012 · External reference
Mucin-Pseudomonas aeruginosa interactions promote biofilm formation and antibiotic resistance
10.1111/j.1365-2958.2005.04941.x · 2006 · External reference
Characterization of biofilm-like structures formed by Pseudomonas aeruginosa in a synthetic mucus medium
10.1186/1471-2180-12-181 · 2012 · External reference
Mucins trigger dispersal of Pseudomonas aeruginosa biofilms
10.1038/s41522-018-0067-0 · 2018 · External reference
The cystic fibrosis lung microenvironment alters antibiotic activity: causes and effects
10.1183/16000617.0055-2021 · 2021 · External reference
Distribution of sialic acids on mucins and gels: a defense mechanism
10.1016/j.bpj.2011.08.058 · 2012 · External reference
N-glycan modifications with negative charge in a natural polymer mucin from bovine submaxillary glands, and their structural role
10.3390/polym13010103 · 2020 · External reference
Mucin binding reduces colistin antimicrobial activity
10.1128/aac.00808-15 · 2015 · External reference
Mucus and mucin environments reduce the efficacy of polymyxin and fluoroquinolone antibiotics against Pseudomonas aeruginosa
10.1021/acsbiomaterials.8b01054 · 2019 · External reference
Culture of calu-3 cells at the air interface provides a representative model of the airway epithelial barrier
10.1007/s11095-006-0255-0 · 2006 · External reference
Mucus models to evaluate the diffusion of drugs and particles
10.1016/j.addr.2017.11.001 · 2018 · External reference
Disassembling the complexity of mucus barriers to develop a fast screening tool for early drug discovery
10.1039/c9tb00957d · 2019 · External reference
Drug diffusion through cystic fibrotic mucus: steady-state permeation, rheologic properties, and glycoprotein morphology
10.1021/js950381s · 1996 · External reference
Cystic fibrosis mucus model to design more efficient drug therapies
10.1021/acs.molpharmaceut.1c00644 · 2022 · External reference
Absorption/metabolism of sulforaphane and quercetin, and regulation of phase II enzymes, in human jejunum in vivo
10.1124/dmd.31.6.805 · 2003 · External reference
Nanoparticle passage through porcine jejunal mucus: microfluidics and rheology
10.1016/j.nano.2016.11.017 · 2017 · External reference
Property profiling of biosimilar mucus in a novel mucus-containing in vitro model for assessment of intestinal drug absorption
10.1016/j.ejpb.2014.01.001 · 2014 · External reference
Mucus-PVPA (mucus Phospholipid Vesicle-based Permeation Assay): an artificial permeability tool for drug screening and formulation development
10.1016/j.ijpharm.2017.12.038 · 2018 · External reference
Mucin glycans signal through the sensor kinase RetS to inhibit virulence-associated traits in Pseudomonas aeruginosa
10.1016/j.cub.2020.09.088 · 2021 · External reference
Mucus, mucins, and cystic fibrosis
2019 · External reference
Community surveillance enhances Pseudomonas aeruginosa virulence during polymicrobial infection
10.1073/pnas.1214550110 · 2013 · External reference
Mucin glycans attenuate the virulence of Pseudomonas aeruginosa in infection
10.1038/s41564-019-0581-8 · 2019 · External reference
Host mucin is exploited by Pseudomonas aeruginosa to provide monosaccharides required for a successful infection
10.1128/mbio.00060-20 · 2020 · External reference
Acidic pH increases airway surface liquid viscosity in cystic fibrosis
10.1172/jci83922 · 2016 · External reference
Targeting iron uptake to control Pseudomonas aeruginosa infections in cystic fibrosis
10.1183/09031936.00124012 · 2013 · External reference
Iron acquisition in the cystic fibrosis lung and potential for novel therapeutic strategies
10.1099/mic.0.000220 · 2016 · External reference
The transcriptional regulator CzcR modulates antibiotic resistance and quorum sensing in Pseudomonas aeruginosa
10.1371/journal.pone.0038148 · 2012 · External reference
Responses of microorganisms to osmotic stress
10.1146/annurev-micro-020518-115504 · 2019 · External reference
Microarray analysis of the osmotic stress response in Pseudomonas aeruginosa
10.1128/jb.188.7.2721-2725.2006 · 2006 · External reference
Rethinking 'secondary' metabolism: physiological roles for phenazine antibiotics
10.1038/nchembio764 · 2006 · External reference
Functional analysis of genes for biosynthesis of pyocyanin and phenazine-1-carboxamide from Pseudomonas aeruginosa PAO1
10.1128/jb.183.21.6454-6465.2001 · 2001 · External reference
Mechanism of pyocyanin- and 1-hydroxyphenazine-induced lung neutrophilia in sheep airways
10.1152/jappl.1998.85.6.2298 · 1998 · External reference
Pseudomonas aeruginosa pyocyanin is critical for lung infection in mice
10.1128/iai.72.7.4275-4278.2004 · 2004 · External reference
Phenazine virulence factor binding to extracellular DNA is important for Pseudomonas aeruginosa biofilm formation
10.1038/srep08398 · 2015 · External reference
A genetic basis for Pseudomonas aeruginosa biofilm antibiotic resistance
10.1038/nature02122 · 2003 · External reference
High-level antibiotic resistance in Pseudomonas aeruginosa biofilm: the ndvB gene is involved in the production of highly glycerol-phosphorylated β-(1→3)-glucans, which bind aminoglycosides
10.1093/glycob/cwq047 · 2010 · External reference
Quorum sensing as antivirulence target in cystic fibrosis pathogens
10.3390/ijms20081838 · 2019 · External reference
A dynamic and intricate regulatory network determines Pseudomonas aeruginosa virulence
10.1093/nar/gks1039 · 2012 · External reference
Impact of coexistence phenotype between Staphylococcus aureus and Pseudomonas aeruginosa isolates on clinical outcomes among cystic fibrosis patients
10.3389/fcimb.2020.00266 · 2020 · External reference
How bacterial adaptation to cystic fibrosis environment shapes interactions between Pseudomonas aeruginosa and Staphylococcus aureus
10.3389/fmicb.2021.617784 · 2021 · External reference
In vivo and in vitro Interactions between Pseudomonas aeruginosa and Staphylococcus spp
10.3389/fcimb.2017.00106 · 2017 · External reference
